Big Pharma’s Child-Vax Windfall
Friday October 21, 2022
On Oct. 20, the Centers for Disease Control and Prevention handed another huge gift to Big Pharma: In a little-publicized meeting, the agency’s Advisory Committee on Immunization Practices voted to recommend adding the Covid vaccine to the childhood and adolescent immunization schedule. This makes the Covid vaccine market vast and indefinite—exposing children to unnecessary risks while shielding drug companies from liability.
Throughout the pandemic, the CDC and the Food and Drug Administration rubber-stamped every iteration of the vaccines that came through the door. So this final outcome is hardly surprising. And yet it still has the power to shock. It never should have come to this. Despite all the “sciencing” that led us here, it is a completely perverse outcome. The Covid bonfire is down to its last fading embers—and now the CDC effectively decrees that every child forever should receive this novel, barely tested, potentially dangerous injection.
The potential profits flowing from this approval are enormous. The Covid injections were all approved under emergency laws that effectively shielded the corporate developers from any liability. This temporary shield would expire in October 2024. When the CDC officially adds the shots to the childhood immunization schedule, all future liability transfers to the National Vaccine Injury Compensation Program, or VICP. The shield extends to adult shots, as well; once the product is covered under VICP, manufacturers become immune against all consumer legal challenges, shifting damages claims to US taxpayers. Having already received FDA approval as “safe and effective,” and with no concern for liability, the manufacturers are free to churn out mRNA injections as they will. Shots and boosters from birth until death, multiplied by every citizen in the nation. Childhood Covid vaccination is the 2021 windfall compounded into eternity.